autologous bone marrow-derived CD34+ stem cell therapy (University of Debrecen)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameautologous bone marrow-derived CD34+ stem cell therapy (University of Debrecen)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionAngiogenesis stimulants

TargetsUpdating

Therapy Area/IndicationsPeripheral arterial occlusive disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryHungary

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Debrecen

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Debrecen

Active IndicationsN/A

Inactive IndicationsPeripheral arterial occlusive disorders

Other Information

ATC CodeN/A